Sesen, Julie
Martinez, Tyra
Busatto, Sara
Poluben, Larysa
Nassour, Hassan
Stone, Caroline
Ashok, Karthik
Moses, Marsha A.
Smith, Edward R.
Ghalali, Aram
Funding for this research was provided by:
Harvard Dubai Foundation
Sweden-America Foundation
Childhood Cancer Fund (TJ2021)
Article History
Received: 19 November 2024
Accepted: 2 January 2025
First Online: 17 February 2025
Declarations
:
: Animal experiments were conducted in compliance with protocols established by the Institutional Animal Care and Use Committee (IACUC) of Boston Children’s Hospital for ensuring animal welfare and minimizing discomfort. The animal ethical clearance protocol number used for the study was 00002258. CSF, tissue and urine were collected in accordance with protocols approved by the Boston Children’s Hospital IRB (IRB#10-417); informed consent was obtained. Tissue microarray, on a slide containing 47 cases of MB was obtained in accordance with protocols approved Children’s Oncology Group (COG) (approved protocol number: ACNS20B1-Q).
: Not applicable.
: The authors declare no competing interests.